Center for Stem Cell and Translational Immunotherapy (CSTI)

Brigham and Women's Hospital, Harvard Medical School

Author : Khalid Shah

Dr. Khalid Shah is the Vice Chair of Research at BWH Neurosurgery and Professor at Harvard Medical School. He directs of the Center for Stem Cell & Translational Immunotherapy at BWH and the joint Center of Excellence in Biomedicine with KACST and BWH. He is also a Principal Faculty at Harvard Stem Cell Institute in Boston. Dr. Shah and his team have pioneered major developments in translational cell therapy field, successfully developing gene edited and engineered cellular therapies for cancer. Dr. Shah holds current positions on numerous councils, advisory and editorial boards in the fields of cell therapy and oncology. In an effort to translate the exciting therapies developed in his laboratory into clinics, he has supported the foundation of biotech companies whose main objective is the clinical translation of therapeutic cells in cancer patients. A prolific innovator, published researcher and author, Dr. Shah is keen to bridge integrate different scientific disciplines to ultimately find a cure for cancer.
Scroll to top